0
Research Letters |

Systemic Uptake of Chlorpromazine After Delivery via Retrobulbar Injection FREE

Ruben Kuruvilla, MD; Priya D. Sahu, MD; Murray A. Meltzer, MD
[+] Author Affiliations

Author Affiliations: Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York.


Arch Ophthalmol. 2012;130(10):1348-1349. doi:10.1001/archophthalmol.2012.662.
Text Size: A A A
Published online

Severe pain can manifest in blind eyes as well as eyes with useful vision.1 Patients who fail conservative therapy with oral analgesics or topical steroid and cycloplegic eyedrops can undergo more aggressive measures. Although enucleation is the definitive treatment, some patients may not be medically or psychologically ready for this.2 As an alternative, retrobulbar alcohol injections can be used. More recently, chlorpromazine, a phenothiazine-class antipsychotic, has gained popularity. Initially described in the 1980s, reports have suggested that it provides superior pain control with a good response rate and fewer complications than alcohol injections.1,3 Previously reported adverse effects due to chlorpromazine injections have all been localized to the intraorbital or periorbital region. Herein, we describe a patient treated with retrobulbar chlorpromazine injection who subsequently developed systemic symptoms similar to those observed in patients receiving enteral chlorpromazine.

A 63-year-old woman visited our clinic 10 years after surgical repair for total rhegmatogenous retinal detachment in her right eye at an outside hospital. Her visual acuity was hand motions, with an afferent pupillary defect and intraocular pressure of 42 mm Hg. B-scan ultrasonography showed persistent retinal detachment.

A retrobulbar injection was performed to alleviate her ocular pain. Two milliliters of 25-mg/mL chlorpromazine was injected with a retrobulbar needle, taking care to ensure the drug was not injected into any major vessels. No local anesthesia was used and no complications were noted during the procedure. The patient left our clinic in stable condition but returned to the hospital 1 hour later with dizziness and palpitations. Her vital signs were unremarkable but her right infraorbital area showed moderate painless swelling without erythema. There were mild conjunctival injection and chemosis but no proptosis, ptosis, or motility deficits. Visual acuity remained unchanged and intraocular pressure was 11 mm Hg. A serum phenothiazine panel drawn 3 hours after injection revealed the concentration of chlorpromazine to be 20 ng/mL (minimum reporting limit was 10 ng/mL). The patient was placed on electrocardiographic monitoring, and her symptoms eventually resolved without intervention. She was discharged from the emergency department and was followed up in our clinic the following day. She reported no further systemic symptoms, her periorbital swelling had resolved, and her eye pain remained subsided.

Chlorpromazine reaches therapeutic systemic levels when used at an oral dosage of 200 to 400 mg/d. Common adverse effects of retrobulbar chlorpromazine injections include transient palpebral edema and chemosis. Transient ptosis, sterile orbital cellulitis, chronic orbital inflammation, neurotrophic corneal ulcer formation, and pigmentary degeneration of the retina have also been described.24 Of the 9 patients in the series by Estafanous et al,1 1 developed nausea and vomiting followed by a brief episode of loss of consciousness. Per the authors' report, it was unclear whether the latter reaction could be directly attributed to the injection or represented a vasovagal response. In the case series of 20 patients by Chen et al2 and the report of 60 patients by McCulley and Kersten,3 no systemic complications were noted.

To our knowledge, this is the first case of adverse effects experienced by a patient after retrobulbar chlorpromazine injection due to infiltration of the drug into systemic circulation. We hypothesize that the mechanism of systemic delivery was either infiltration of the drug into one of the smaller arterioles of the retrobulbar compartment or extravasation through the dural sheath. The latter mechanism would seem more likely considering the 1991 radiographic study by Zahl et al5 that revealed tracking along the optic nerve sheath and intracranial spread of local anesthetic after a peribulbar injection.

In summary, we urge caution and vigilance during and after retrobulbar chlorpromazine injections. Although the risk of systemic spreading of any medication injected into the retrobulbar space is small, awareness of the anticholinergic and α-adrenergic antagonistic activity of chlorpromazine is vital for patient counseling and treatment.

Correspondence: Dr Meltzer, Department of Ophthalmology, Mount Sinai School of Medicine, One Gustave L. Levy Place, PO Box 1183, New York, NY 10029 (murray.meltzer@mssm.edu).

Financial Disclosure: None reported.

Estafanous MF, Kaiser PK, Baerveldt G. Retrobulbar chlorpromazine in blind and seeing painful eyes.  Retina. 2000;20(5):555-558
PubMed   |  Link to Article
Chen TC, Ahn Yuen SJ, Sangalang MA, Fernando RE, Leuenberger EU. Retrobulbar chlorpromazine injections for the management of blind and seeing painful eyes.  J Glaucoma. 2002;11(3):209-213
PubMed   |  Link to Article
McCulley TJ, Kersten RC. Periocular inflammation after retrobulbar chlorpromazine (thorazine) injection.  Ophthal Plast Reconstr Surg. 2006;22(4):283-285
PubMed   |  Link to Article
Hauck MJ, Lee HH, Timoney PJ, Shoshani Y, Nunery WR. Neurotrophic corneal ulcer after retrobulbar injection of chlorpromazine.  Ophthal Plast Reconstr Surg. 2012;28(3):e74-e76
PubMed   |  Link to Article
Zahl K, Nassif JM, Meltzer MA, Som P. Simulated peribulbar injection of anesthetic.  Ann Ophthalmol. 1991;23(3):114-117
PubMed

Figures

Tables

References

Estafanous MF, Kaiser PK, Baerveldt G. Retrobulbar chlorpromazine in blind and seeing painful eyes.  Retina. 2000;20(5):555-558
PubMed   |  Link to Article
Chen TC, Ahn Yuen SJ, Sangalang MA, Fernando RE, Leuenberger EU. Retrobulbar chlorpromazine injections for the management of blind and seeing painful eyes.  J Glaucoma. 2002;11(3):209-213
PubMed   |  Link to Article
McCulley TJ, Kersten RC. Periocular inflammation after retrobulbar chlorpromazine (thorazine) injection.  Ophthal Plast Reconstr Surg. 2006;22(4):283-285
PubMed   |  Link to Article
Hauck MJ, Lee HH, Timoney PJ, Shoshani Y, Nunery WR. Neurotrophic corneal ulcer after retrobulbar injection of chlorpromazine.  Ophthal Plast Reconstr Surg. 2012;28(3):e74-e76
PubMed   |  Link to Article
Zahl K, Nassif JM, Meltzer MA, Som P. Simulated peribulbar injection of anesthetic.  Ann Ophthalmol. 1991;23(3):114-117
PubMed

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Scenario